Serine racemase Antibodies

Santa Cruz Biotechnology delivers a wide array of Serine Racemase monoclonal antibodies for research in understanding serine racemase's role in various biological processes. Serine Racemase monoclonal antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Serine racemase is an enzyme that catalyzes the conversion of L-serine to D-serine, a critical neuromodulator in the central nervous system. D-serine plays a vital role in synaptic plasticity and is implicated in various neurological disorders, including schizophrenia and Alzheimer's disease. Understanding the function and regulation of serine racemase is essential for elucidating its contributions to neurobiology and potential therapeutic targets. Researchers worldwide rely on Serine Racemase monoclonal antibodies to advance their studies in neuroscience and related fields. The specificity and reliability of Serine Racemase monoclonal antibodies enable precise detection and analysis of this enzyme in diverse experimental settings. Current research utilizing Serine Racemase monoclonal antibodies continues to reveal new insights into neurological pathways and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by providing reliable tools for researchers investigating neurological disorders and brain function.